Discovery by North Carolina researchers described at biophysical society meeting may advance development of vaccines to fight global, mosquito-borne scourge Dengue fever, an infectious tropical disease caused by a mosquito-borne virus, ...
Tags: Dengue Virus
Drugs.com, the leading online clinical drug resource, and TrialReach are partnering to provide patients with information and access to treatments that are still under development. Announced today at Rock Health, this new partnership will ...
Vector Capital, private equity firm focused on value-oriented investments in technology companies, has sold Certara, a provider of drug development software and services, to Arsenal Capital Partners, a US-based based private equity firm. ...
Tags: Vector Capital, Arsenal Capital
Evotec has announced a collaboration with the Johnson & Johnson Innovation Center in California to identify new targets for Alzheimer's disease drug discovery and development. Under the terms of the agreement, Janssen Pharmaceuticals ...
Tags: Evotec, Johnson, innovation, Alzheimer
Alzheon announced the launch of the company, the securing of initial private financing, and the signing of an exclusive license agreement to a novel clinical drug candidate for Alzheimer’s disease, a family of analogs, and a drug ...
Tags: Alzheon, Alzheimer's Disease
If you’ve been around this industry for twenty years or so, you may remember the origins of the best-of-breed WMS market we know today. The catalyst was compliance labeling. Major retailers like Walmart began to require their ...
The UK biotechnology and personalized medicine company Epistem has received Good Clinical Laboratory Practice (GCLP) accreditation for its contract research division's histology and immunohistochemistry (IHC) laboratories. The contract ...
Tags: biotechnology, personalized medicine, Clinical Laboratory
Pharmaceutical and biotech companies are outsourcing research in order to develop innovative products that meet the rising demand for therapeutics across a range of diseases. The willingness of contract research organisations (CROs) to ...
Tags: Pharmaceutical, CROs, innovative products
Galapagos has reached a milestone in its immuno-inflammation alliance with GlaxoSmithKline (GSK) by delivering a fifth pre-clinical drug candidate. Galapagos CEO Onno van de Stolpe said the company has identified five candidate drugs of ...
Tags: immuno inflammation, GSK, clinical drug, drug
Clinical research organization PRA has opened a second office in China to house its continued expansion in China and the Asia Pacific region. The new Beijing facility is expected to enhance PRA local project teams' ability in meeting the ...
Tags: Clinical research, clinical drug development, clinical sites